- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05150964
Measuring Comfort and Clarity With Low Gain Feature in Pediatric Hearing Aid Users
May 18, 2023 updated by: Sonova AG
Measuring Comfort and Clarity Using Low Gain Feature in Pediatric Hearing Aid Users
Comfort and clarity of speech will be measured in hearing impaired children age 8-17 using standard speech processing algorithm with a soft speech enhancer feature, referred to as the Adaptive Situational Gain (ASG) feature in study documents.
Study Overview
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tempe, Arizona, United States, 85281
- Arizona State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 17 years (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- clinical diagnosis of mild, moderate, or moderate-severe sensorineural hearing loss
- Must use oral mode of communication
- must speak English
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
One group will be fit with commercially available hearing aids that will have different program settings
|
receiver in the canal devices with custom earmolds
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speech Reception Threshold
Time Frame: Initial appointment (day 1 of study) and 2nd appointment (Day 14 of study)
|
A familiar spondee word list is presented at varying dB (decibel) levels.
Threshold is defined as the lowest dB level at which a correct response occurs for two out of three ascending trials.
Testing was completed in two, two-hour test sessions occurring two weeks apart.
A different fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session, and counterbalanced across participants.
Each session consisted of testing with the ASG (Adaptive Situational Gain) feature on and off.
The lower the number (dB level), the softer the participant is able to repeat the words correctly two out of three times.
|
Initial appointment (day 1 of study) and 2nd appointment (Day 14 of study)
|
|
Word Recognition Score With Words Presented at 40 dB SPL (Decibel Sound Pressure Level) and 70 dB SPL.
Time Frame: Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
|
Familiar monosyllabic word list presented at 40 dB and 70 dB.
Percentage of words correctly repeated is calculated.
Testing was completed in two, two-hour test sessions occurring two weeks apart.
A different fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session and counterbalanced across participants such that one test session consisted of testing with one prescription, either NAL or DSL, but with both levels (40 and 70 dB) and with both ASG (Adaptive Situational Gain) settings, on and off.
The higher the score, the better the word recognition in each condition.
|
Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
|
|
Multi-word Recognition at 40 dB SPL and 70 dB SPL
Time Frame: Initial appointment (Day 1 of study) and 2nd appointment (Day 14 of study)
|
Out of a list of seven words, the participant repeats back as many words as they can recall.
Percentage of correct words repeated back is calculated.
Testing was completed in two, two-hour test sessions occurring two weeks apart.
One fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session and counterbalanced across participants such that one test session consisted of testing with one prescription, either NAL or DSL, but with both levels (40 and 70 dB) and with both ASG (Adaptive Situational Gain) settings, on and off.
A higher percentage score indicates better multi-word recognition.
|
Initial appointment (Day 1 of study) and 2nd appointment (Day 14 of study)
|
|
Nonword Detection Presented at 40 dB SPL and at 70 dB SPL.
Time Frame: Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
|
A list of 10 3-word phrases are presented to the participant.
The participant indicates if the phrase contains a nonsense word by selecting the numbered response button (i.e.
"1", "2", or "3") that corresponds to the position oof the nonsense word in the phrase.
Testing was completed in two, two-hour test sessions occurring two weeks apart.
A different fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session and counterbalanced across participants such that one test session consisted of testing with one prescription, either NAL or DSL, but with both levels (40 and 70 dB) and with both ASG (Adaptive Situational Gain) settings, on and off. .
The score is the percent correct, a higher score is better.
|
Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
|
|
Rapid Word Learning With Stimuli Presented at 40 dB SPL and at 70 dB SPL.
Time Frame: Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
|
A word learning task used to determine participant's ability to associate novel/nonsense words with novel images as rapidly as possible.
Five nonsense words are paired with five novel images displayed on response buttons.
The words are presented randomly 10 times each.
The participant selects one picture per word.
Scores are presented as percent correct.
A higher percentage indicates better word learning.
Testing was completed in two, two-hour test sessions occurring two weeks apart.
A different prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session and counterbalanced across participants such that one test session consisted of testing with one prescription, either NAL or DSL, but with both levels (40 and 70 dB) and with both ASG (Adaptive Situational Gain) settings, on and off.
|
Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
|
|
Subjective Preference for the Adaptive Situational Gain Feature With Each Fitting Formula
Time Frame: 2nd appointment (day 14 of study)
|
Participants will rank preference for the ASG feature (either on or off) in each fitting (NAL and DSL) after listening to audio file.
|
2nd appointment (day 14 of study)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Actual)
October 15, 2021
Study Completion (Actual)
May 29, 2022
Study Registration Dates
First Submitted
September 28, 2021
First Submitted That Met QC Criteria
November 25, 2021
First Posted (Actual)
December 9, 2021
Study Record Updates
Last Update Posted (Actual)
May 19, 2023
Last Update Submitted That Met QC Criteria
May 18, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SRF-379
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Wonju Severance Christian HospitalRecruitingHearing Loss, Sudden | Sudden Hearing Loss | Hearing Loss, Idiopathic Sudden Sensorineural | SSNHL(Sudden Sensory Neural Hearing Loss)Korea, Republic of
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Phonak Audeo hearing aid
-
Sonova AGCompletedHearing Loss, Bilateral or UnilateralUnited States
-
Sonova AGHearts for HearingCompleted
-
University of South FloridaRecruiting
-
Sonova AGCompletedHearing LossUnited States
-
Sonova AGTerminatedHearing LossUnited States
-
Sonova AGHearts for HearingCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralUnited States
-
Sonova AGCompleted
-
Sonova AGCompleted